H Ishikawa

817 total citations
31 papers, 675 citations indexed

About

H Ishikawa is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, H Ishikawa has authored 31 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Genetics. Recurrent topics in H Ishikawa's work include Signaling Pathways in Disease (3 papers), Bacterial Genetics and Biotechnology (3 papers) and Cancer Cells and Metastasis (2 papers). H Ishikawa is often cited by papers focused on Signaling Pathways in Disease (3 papers), Bacterial Genetics and Biotechnology (3 papers) and Cancer Cells and Metastasis (2 papers). H Ishikawa collaborates with scholars based in Japan, United States and Germany. H Ishikawa's co-authors include Hiroji Aiba, Teppei Morita, Keisuke Yamada, Nobuya Kurikawa, Shoko Kuroda, Kiyoshi Arai, Makoto Mizuno, Kazumasa Aoki, Naoko Ubukata and Yuka Morikawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

H Ishikawa

30 papers receiving 655 citations

Peers

H Ishikawa
Arulkumaran Shanmugam United States
Dizhe Eb Russia
V Bailly Belgium
Karin Zeh United States
M. Kéramidas France
Wuxia Fu United States
Jean‐Pierre Couty France
Huanchun Zhang United States
Yumiko Sakai Japan
Frédérique Bulle France
Arulkumaran Shanmugam United States
H Ishikawa
Citations per year, relative to H Ishikawa H Ishikawa (= 1×) peers Arulkumaran Shanmugam

Countries citing papers authored by H Ishikawa

Since Specialization
Citations

This map shows the geographic impact of H Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Ishikawa more than expected).

Fields of papers citing papers by H Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Ishikawa. The network helps show where H Ishikawa may publish in the future.

Co-authorship network of co-authors of H Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of H Ishikawa. A scholar is included among the top collaborators of H Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Ishikawa. H Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Namekata, Kazuhiko, Xiaoli Guo, Sari Honda, et al.. (2023). Neuroprotection and axon regeneration by novel low-molecular-weight compounds through the modification of DOCK3 conformation. Cell Death Discovery. 9(1). 166–166. 5 indexed citations
2.
3.
Noguchi, Shingo, H Ishikawa, Kenichi Wakita, Fumio Matsuda, & Hiroshi Shimizu. (2020). Direct and quantitative analysis of altered metabolic flux distributions and cellular ATP production pathway in fumarate hydratase-diminished cells. Scientific Reports. 10(1). 13065–13065. 12 indexed citations
4.
Arai, Kiyoshi, Yuka Morikawa, Naoko Ubukata, et al.. (2015). Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist. European Journal of Pharmacology. 761. 226–234. 112 indexed citations
5.
6.
7.
Ishikawa, H, Tohru Nakanishi, A. Nawa, Yoshiyuki Suzuki, & Kazuo Kuzuya. (2001). 3-Hour infusion of single-agent paclitaxel for recurrent ovarian cancer. International Journal of Clinical Oncology. 6(3). 128–131. 4 indexed citations
8.
Nakanishi, Toru, et al.. (2001). Association between menopausal state and prognosis of endometrial cancer. International Journal of Gynecological Cancer. 11(6). 483–487. 3 indexed citations
9.
Nakanishi, Toru, H Ishikawa, A. Nawa, et al.. (2000). The significance of tumor size in clinical stage IB cervical cancer: Can a cut-off figure be determined?. International Journal of Gynecological Cancer. 10(5). 397–401. 13 indexed citations
10.
Ishikawa, H, et al.. (1999). A novel calcitonin receptor gene in human osteoclasts from normal bone marrow. FEBS Letters. 458(3). 409–414. 14 indexed citations
11.
Saito, Yoshihiro, Norio Mitsuhashi, Hiroyuki Sakurai, et al.. (1999). Apoptosis and Appearance of Trp53-Positive Micronuclei in Murine Tumors with Different Radioresponses In Vivo. Radiation Research. 152(5). 462–462. 5 indexed citations
12.
Ishikawa, H, et al.. (1999). Large-scale preparation of recombinant human calcitonin from a multimeric fusion protein produced in Escherichia coli. Journal of Bioscience and Bioengineering. 87(3). 296–301. 3 indexed citations
13.
Akedo, Ikuko, H Ishikawa, Tomiyo Nakamura, et al.. (1998). Three Cases with Familial Adenomatous Polyposis Diagnosed as Having Malignant Lesions in the Course of a Long-Term Trial Using Docosahexanoic Acid (DHA)-Concentrated Fish Oil Capsules. Japanese Journal of Clinical Oncology. 28(12). 762–765. 20 indexed citations
14.
Kiguchi, Kazushige, et al.. (1998). Establishment and characterization of melanoma cell line derived from malignant melanoma of human uterine cervix.. PubMed. 11(2). 93–100. 3 indexed citations
15.
Ishiwata, Isamu, Kaoru Kiguchi, Chieko Ishiwata, et al.. (1997). Histogenesis of hollow cell ball structure of ovarian and endometrial adenocarcinoma cells in vivo and in vitro.. PubMed. 10(3). 209–16. 1 indexed citations
16.
Ishikawa, H, et al.. (1996). The effect of TNP-470 on cell proliferation and urokinase-type plasminogen activator and its inhibitor in human lung cancer cell lines.. PubMed. 1(6). 390–6. 7 indexed citations
17.
Kojima, M., Fumitaka Kikkawa, Osamu Maeda, et al.. (1994). Sensitisation of human ovarian carcinoma cells to cis-diamminedichloroplatinum (II) by amphotericin B in vitro and in vivo. European Journal of Cancer. 30(6). 773–778. 8 indexed citations
18.
Kikkawa, Fumitaka, M. Kojima, Osamu Maeda, et al.. (1993). Potentiating effect of amphotericin B on five platinum anticancer drugs in human cis-diamminedichloroplatinum (II) sensitive and resistant ovarian carcinoma cells.. PubMed. 13(4). 891–6. 12 indexed citations
19.
Ishiwata, Isamu, et al.. (1990). Characterization of Krukenberg tumor cell line, especially the biological relationship between cancer and stromal cells. Experimental Pathology. 38(2). 97–108. 4 indexed citations
20.
Imanaka, Tadayuki, H Ishikawa, & Shuichi Aiba. (1986). Complete nucleotide sequence of the low copy number plasmid pRAT11 and replication control by the RepA protein inBacillus subtilis. Molecular and General Genetics MGG. 205(1). 90–96. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arulkumaran Shanmugam Breakdown of academic impact, for papers by Dizhe Eb Breakdown of academic impact, for papers by V Bailly Breakdown of academic impact, for papers by Karin Zeh Breakdown of academic impact, for papers by M. Kéramidas Breakdown of academic impact, for papers by Wuxia Fu Breakdown of academic impact, for papers by Jean‐Pierre Couty Breakdown of academic impact, for papers by Huanchun Zhang Breakdown of academic impact, for papers by Yumiko Sakai Breakdown of academic impact, for papers by Frédérique Bulle
Rankless by CCL
2026